Extensive FDG uptake and its modification with corticosteroid in a granuloma rat model: An experimental study for differentiating granuloma from tumors

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 34, Issue 12, 2007, Pages 2096-2105

  Zhao, Songji ^a   Kuge, Yuji ^a,b   Kohanawa, Masashi ^a   Takahashi, Toshiyuki ^c   Kawashima, Hidekazu ^b   Temma, Takashi ^b   Takei, Toshiki ^a   Zhao, Yan ^a   Seki, Koh Ichi ^d   Tamaki, Nagara ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c Hokkaido Gastroenterology Hospital   (Japan)

^d HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Corticosteroid; FDG; Granuloma; Rat; Tumor

Indexed keywords

BCG VACCINE; CORTICOSTEROID; FLUORODEOXYGLUCOSE F 18; METHYLPREDNISOLONE ACETATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG UPTAKE; EPITHELIOID CELL; GRANULOMA; HEPATOMA CELL; HISTOLOGY; LIVER CELL CARCINOMA; LYMPHOCYTIC INFILTRATION; MALE; MYCOBACTERIUM BOVIS; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; RADIOACTIVITY; RAT; SARCOIDOSIS; TUMOR;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; DIAGNOSIS, DIFFERENTIAL; DISEASE MODELS, ANIMAL; FLUORODEOXYGLUCOSE F18; GLUCOCORTICOIDS; GRANULOMA; LIVER NEOPLASMS; MALE; METABOLIC CLEARANCE RATE; PREDNISOLONE; RADIOPHARMACEUTICALS; RATS; RATS, WISTAR;

EID: 36749008981     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-007-0529-8     Document Type: Article

References (30)

1. Dimitrakopoulou-Strauss A, Strauss LG, Heichel T, Wu H, Burger C, Bernd L, et al. The role of quantitative (18)F-FDG PET studies for the differentiation of malignant and benign bone lesions. J Nucl Med 2002;43:510-8.
2. Brudin LH, Valind S, Rhodes CG, Pantin CF, Sweatman M, Jones T, et al. Fluorine-18 deoxyglucose uptake in sarcoidosis measured with positron emission tomography. Eur J Nucl Med 1994;21:297-305.
3. Lewis PJ, Salama A. Uptake of fluorine-18-fluorodeoxyglucose in sarcoidosis. J Nucl Med 1994;35:1647-9.
4. Ohtsuka T, Nomori H, Watanabe K, Naruke T, Orikasa H, Yamazaki K, et al. False-positive findings on [18F]FDG-PET caused by non-neoplastic cellular elements after neoadjuvant chemoradiotherapy for non-small cell lung cancer. Jpn J Clin Oncol 2005;35:271-3.
5. van Waarde A, Cobben DC, Suurmeijer AJ, Maas B, Vaalburg W, de Vries EF, et al. Selectivity of 18F-FLT and FDG for differentiating tumor from inflammation in a rodent model. J Nucl Med 2004;45:695-700.
6. Zhao S, Kuge Y, Tsukamoto E, Mochizuki T, Kato T, Hikosaka K, et al. Effects of insulin and glucose loading on FDG uptake in experimental malignant tumours and inflammatory lesions. Eur J Nucl Med 2001;28:730-5.
7. Zhao S, Kuge Y, Mochizuki T, Takahashi T, Nakada K, Sato M, et al. Biologic correlates of intratumoral heterogeneity in FDG distribution with regional expression of glucose transporters and hexokinase-II in experimental tumor. J Nucl Med 2005;46:675-82.
8. Gemma H, Sato A. Effect of glucocorticoid on lung tissue and bronchus-associated lymphoid tissue of experimental granulomatous lung. Kekkaku 1989;64:387-99.
9. Whiteland JL, Nicholls SM, Shimeld C, Easty DL, Williams NA, Hill TJ. Immunohistochemical detection of T-cell subsets and other leukocytes in paraffin-embedded rat and mouse tissues with monoclonal antibodies. J Histochem Cytochem 1995;43:313-20.
10. Watanabe M, Okada H, Shimizu K, Omura T, Yoshikawa E, Kosugi T, et al. A high resolution animal PET scanner using compact PS-PMT detectors. IEEE Trans Nucl Sci 1997;44:1277-82.
11. Schrier DJ, Ripani LM, Katzenstein AL, Moore VL. Role of angiotensin-converting enzyme in bacille Calmette-Guerin-induced granulomatous inflammation. Increased angiotensin-converting enzyme levels in lung lavage and suppression of inflammation with captopril. J Clin Invest 1982;69:651-7.
12. Sandor M, Weinstock JV, Wynn TA. Granulomas in schistosome and mycobacterial infections: a model of local immune responses. Trends Immunol 2003;24:44-52.
13. Chang JM, Lee HJ, Goo JM, Lee HY, Lee JJ, Chung JK, et al. False positive and false negative FDG-PET scans in various thoracic diseases. Korean J Radiol 2006;7:57-69.
14. du Bois RM. Corticosteroids in sarcoidosis: friend or foe? Eur Respir J 1994;7:1203-9.
15. Osman S, Danpure HJ. The use of 2-[18F]fluoro-2-deoxy-D-glucose as a potential in vitro agent for labeling human granulocytes for clinical studies by positron emission tomography. Int J Rad Appl Instrum B 1992;19:183-90.
16. Borregaard N, Herlin T. Energy metabolism of human neutrophils during phagocytosis. J Clin Invest 1982;70:550-7.
17. Kubota R, Yamada S, Kubota K, Ishiwata K, Tamahashi N, Ido T. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med 1992;33:1972-80.
18. Winchester RJ, Kunkel HG. The human Ia system. Adv Immunol 1979;28:221-92.
19. Costabel U, Bross KJ, Ruhle KH, Lohr GW, Matthys H. Ia-like antigens on T-cells and their subpopulations in pulmonary sarcoidosis and in hypersensitivity pneumonitis. Analysis of bronchoalveolar and blood lymphocytes. Am Rev Respir Dis 1985;131:337-42.
20. Siltzbach LE. Effects of cortisone in sarcoidosis: a study of thirteen patients. Am J Med 1952;12:139-60.
21. Milman N. Oral and inhaled corticosteroids in the treatment of pulmonary sarcoidosis-a critical reappraisal. Sarcoidosis Vasc Diffuse Lung Dis 1998;15:150-7.
22. Hashimoto S, Shirato H, Hosokawa M, Nishioka T, Kuramitsu Y, Matushita K, et al. The suppression of metastases and the change in host immune response after low-dose total-body irradiation in tumor-bearing rats. Radiat Res 1999;151:717-24.
23. West KM. Comparison of the hyperglycemic effects of glucocorticoids in human beings; the effect of heredity on responses to glucocorticoids. Diabetes 1957;6:168-75.
24. Pellacani A, Fornengo P, Bruno A, Ceruti C, Mioletti S, Curto M, et al. Acute methylprednisolone administration induces a transient alteration of glucose tolerance and pyruvate dehydrogenase in humans. Eur J Clin Invest 1999;29:861-7.
25. Wahl RL, Henry CA, Ethier SP. Serum glucose: effects on tumor and normal tissue accumulation of 2-[F-18]-fluoro-2-deoxy-D-glucose in rodents with mammary carcinoma. Radiology 1992;183:643-7.
26. Lindholm P, Minn H, Leskinen-Kallio S, Bergman J, Ruotsalainen U, Joensuu H. Influence of the blood glucose concentration on FDG uptake in cancer-a PET study. J Nucl Med 1993;34:1-6.
27. Zhao S, Kuge Y, Nakada K, Mochizuki T, Takei T, Okada F, et al. Effect of steroids on [18F]fluorodeoxyglucose uptake in an experimental tumour model. Nucl Med Commun 2004;25:727-30.
28. Amrein PC, Larson SM, Wagner HN Jr. An automated system for measurement of leukocyte metabolism. J Nucl Med 1974; 15:352-5.
29. Wudel LJ Jr, Delbeke D, Morris D, Rice M, Washington MK, Shyr Y, et al. The role of [18F]fluorodeoxyglucose positron emission tomography imaging in the evaluation of hepatocellular carcinoma. Am Surg 2003; 69:117-24.
30. Lee KH, Ko BH, Paik JY, Jung KH, Choe YS, Choi Y, et. al. Effects of anesthetic agents and fasting duration on 18F-FDG biodistribution and insulin levels in tumor-bearing mice. J Nucl Med 2005;46:1531-6.